|
|
|
|
ImmunexPhiladelphia Inquirer, ...developing together. The acquisition was the third major purchase for Amgen since 2002, when it paid $11 billion to buy Immunex Corp. and ... News For Your Web Site Jan 9, 2006 dBusinessNews Seattle (press release), Dr. Gillis, a biotech pioneer, co-founded both Immunex and Corixa and served as chairman and chief executive officer of both companies. ... Seattle biotech strikes deal with drug giant Jan 4, 2006 Seattle Post Intelligencer Founded in 2002 by former executives of Chiron, Immunex and Xcyte Therapies, Trubion employs just 40 people at its downtown Seattle headquarters. ... Trubion Starts New Year With Potential $840M Wyeth Deal Jan 3, 2006 BioWorld Online (subscription), Enbrel was first developed at Immunex Corp., of Seattle, in collaboration with American Home Products. Immunex later merged with ... Wyeth, Trubion target arthritis, cancer Jan 3, 2006 Reuters He noted that several top executives of Trubion once worked at Immunex, the US biotech company that developed Enbrel with Wyeth, which was then called American ... Amgen Buys Abgenix for $2.2B Dec 16, 2005 Red Herring, The two companies have been partnering on developing a cancer treatment known as panitumumab since 2002, when Amgen acquired Immunex. ... Amgen Buys a Potential Blockbuster Dec 15, 2005 BusinessWeek ..."A WONDERFUL ACHIEVEMENT." As one analyst in the post-deal call pointed out, when Amgen bought Immunex in 2002 for $10 billion, it predicted that Immunex's ... Amgen to Buy Abgenix, Getting Complete Control of New Colon Cancer ... Dec 14, 2005 New York Times, In 2002, it paid about $10 billion for Immunex to obtain the big-selling rheumatoid arthritis drug, Enbrel. The Immunex acquisition ... Amgen to Acquire Abgenix for $2.2 Billion in Cash (Update3) Dec 14, 2005 Bloomberg The acquisition would be Amgen's biggest since it bought Immunex in 2002 for $8.8 billion, gaining the rheumatoid arthritis drug Enbrel. ... Abgenix German Shares Jump on Amgen's $2.2 Billion Cash Offer Dec 15, 2005 Bloomberg It would be Amgen's biggest transaction since the company bought Immunex in 2002 for $8.8 billion, gaining the rheumatoid arthritis drug Enbrel. ... Ex-Dendreon exec joins VLST Corp. Jan 6, 2006 Seattle Post Intelligencer ...executive chairman. Gillis, co-founder of Immunex and Corixa, is a partner in the Seattle office of ARCH Venture Partners. Simonetti's ... Simonetti, Gillis join VLST Jan 6, 2006 Seattle Post Intelligencer ...executive chairman. Gillis, co-founder of Immunex and Corixa, is a new partner in the Seattle office of Arch Venture Partners. Arch ... Biotech behemoth beefs up Dec 15, 2005 Los Angeles Daily News, After buying Immunex in 2002, Thousand Oaks-based Amgen began working closely with Abgenix on a development and commercialization strategy for panitumumab. ... Amgen to acquire Abgenix for $2.2bn Dec 15, 2005 New Ratings The acquisition marks the largest one since Amgen took over Immunex in 2002 for $8.8 billion to gain the rheumatoid arthritis drug Enbrel. ... Amgen seals deal to buy Abgenix for $2.2 billion Dec 15, 2005 9NEWS.com, ...a drug for colon, head and neck cancers the companies have been developing jointly since 2002 under an agreement Amgen assumed with its purchase of Immunex. ... Amgen to Buy Drug Firm Dec 15, 2005 Los Angeles Times, The acquisition confirms Amgen's enthusiasm for Panitumumab, a drug that came to Amgen as a result of its 2002 purchase of Immunex Corp., Abgenix's original ... Amgen to acquire biotech working on cancer drugs Dec 15, 2005 Seattle Times, ...are developing. Abgenix had earlier sold half the drug's future profits to Seattle's Immunex, which Amgen acquired in 2002. Amgen ... Amgen to acquire Abgenix for $2.2 billion Dec 15, 2005 San Jose Mercury News, The drug would have been Abgenix's first commercial product. Abgenix had been developing panitumumab with Immunex, which Amgen acquired in 2002. ... Psoriasis Drug May Also Clear Up Depression and Fatigue Dec 15, 2005 CNN ...patients with psoriasis with high levels of depression and fatigue," they said. The study was funded by Immunex, which markets Enbrel. Amgen Offers To Buy Out Abgenix For $2.2B In Cash Dec 14, 2005 BioWorld Online (subscription), ...a monoclonal antibody for colorectal cancer partnered with Amgen, which began working with Abgenix on the compound after acquiring Immunex Corp., of Seattle ... Amgen to buy Abgenix Dec 14, 2005 Providence Journal (subscription), Abgenix had earlier sold half the drug's future profits to Immunex Corp., which Amgen acquired in 2002. Abgenix is also developing an osteoporosis drug. ... Amgen to purchase Abgenix Dec 15, 2005 Contra Costa Times, Amgen's partnership with Abgenix began in 2002, when the Thousand Oaks-based company took over co-development of panitumumab from Immunex Corp. ... Amgen to Acquire Abgenix for $22.50 Per Share; Provides Amgen With ... Dec 14, 2005 Finanzen.net, ...panitumumab.Working closely with Abgenix under a co-development agreement thatAmgen assumed as a result of its acquisition of Immunex Corporation in2002, Amgen ... Psoriasis drug may also cut depression: study Dec 14, 2005 Herald News Daily, Enbrel was originally discovered by Immunex, now part of Amgen, and jointly developed with Wyeth, which markets the product outside North America. |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |